Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to ...
Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA test results from 450 prostate cancer specimens. The findings suggest that ...
CONCLUSION: A patient’s prognosis is predicted by applying a classification of macroscopic completeness on a rectal resection specimen. We conclude that pathologists are able to judge the quality of ...
The funding, worth AUD $27 million, will progress clinical development and regulatory milestones for its Elora imaging system ...
Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutations LEXINGTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- iSpecimen ...
(RTTNews) - Quest Diagnostics (DGX), a diagnostic services provider, announced Wednesday a new FDA-cleared human papillomavirus (HPV) self-collection solution aimed at broadening access to HPV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results